Clinical trial Recruiting at 1 site Observational Ages 18 to 65

Inflammatory biomarkers in blood and appendix tissue in acute appendicitis

Official title: Evaluation of Systemic and Tissue Level Inflammatory Response in Acute Appendicitis Using Multiple Biomarkers

Run by Haydarpasa Numune Training and Research Hospital · NCT07926165 · Data updated 2026-11-12

This study tests whether blood and appendix tissue biomarkers correlate with how severe a patient’s acute appendicitis is, to help distinguish uncomplicated from complicated cases.

More Appendicitis Acute trials

Quick facts

Study typeObservational
Ages18 Years to 65 Years
SexAll
Enrollment60 (estimated)
SponsorHaydarpasa Numune Training and Research Hospital
Academic / other
Drugs / interventionschemotherapy
Locations1 site (Istanbul, Istanbul)
StatusRecruiting
StartedJuly 12, 2026
Main results expectedJanuary 12, 2027
Study endsMay 27, 2027
Registry record updatedNovember 9, 2026
Trial IDNCT07926165 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–65 with suspected acute appendicitis who are scheduled for appendectomy and can consent, with suitable tissue and clinical data available.

Probably not a fit

Patients without a favorable biomarker profile or those not experiencing varied inflammatory responses may not see a direct benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective observational study recruits adults with suspected acute appendicitis who are scheduled for appendectomy. It measures multiple inflammatory biomarkers in blood and in appendix tissue, and analyzes their relationships with disease severity and standard clinical findings. The goal is to see if tissue and systemic biomarkers together reflect the level of inflammation and can improve severity assessment beyond current methods. The intervention is limited to the surgical procedure (appendectomy) and biomarker analyses on collected specimens. Enrollment is at an Istanbul hospital with defined inclusion and exclusion criteria to ensure reliable data.

Why it matters

Potential benefit: If successful, findings could improve preoperative assessment and decision-making for acute appendicitis by better predicting which patients have uncomplicated versus complicated disease.

How similar studies have gone: Previous work has explored systemic markers like CRP and NLR in appendicitis, but this study adds tissue biomarkers to better reflect local inflammation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Adults aged 18-65 years. Willingness to participate in the study and provision of written informed consent.

Suspected acute appendicitis based on clinical, laboratory, and/or imaging findings.

Scheduled for appendectomy following general surgical evaluation. Availability of an appendectomy specimen suitable for postoperative histopathological examination.

Availability of sufficient clinical and laboratory records for study evaluation.

Exclusion Criteria:

Age younger than 18 years or older than 65 years. Refusal to participate or failure to provide written informed consent. Presence of an active infection that may affect the systemic inflammatory response during the preoperative period.

Concomitant active infectious diseases, including pneumonia, urinary tract infection, or sepsis.

Chronic inflammatory or autoimmune diseases, including rheumatoid arthritis, inflammatory bowel disease, or systemic lupus erythematosus.

History of malignancy or active malignancy. Chronic renal failure or advanced liver failure. Use of immunosuppressive therapy. Use of corticosteroids, chemotherapy, or biological agents. Preoperative use of antibiotics or anti-inflammatory medications at a level that may significantly affect inflammatory biomarker measurements.

Pregnancy or breastfeeding. Identification of additional intra-abdominal pathology unrelated to appendicitis during appendectomy.

Failure to confirm acute appendicitis on postoperative histopathological examination.

Inadequate biological sample quantity or failure to store biological samples under appropriate conditions.

Where it's running

  • Haydarpaşa Numune Training and Research Hospital
    Istanbul, Istanbul, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.